Detalles de la búsqueda
1.
2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting.
Support Care Cancer
; 25(1): 303-308, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27815710
2.
Phase II study of fosaprepitant + 5HT3 receptor antagonist + dexamethasone in patients with germ cell tumors undergoing 5-day cisplatin-based chemotherapy: a Hoosier Cancer Research Network study.
Support Care Cancer
; 24(7): 2837-42, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26838019
3.
Salvage therapy with high-dose chemotherapy and peripheral blood stem cell transplant in patients with primary mediastinal nonseminomatous germ cell tumors.
Biol Blood Marrow Transplant
; 19(1): 161-3, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22892555
4.
Perceptions of masculinity and self-image in adolescent and young adult testicular cancer survivors: implications for romantic and sexual relationships.
Psychooncology
; 20(7): 738-45, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20878864
5.
High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors.
N Engl J Med
; 357(4): 340-8, 2007 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-17652649
6.
Fluoxetine versus placebo in advanced cancer outpatients: a double-blinded trial of the Hoosier Oncology Group.
J Clin Oncol
; 21(10): 1937-43, 2003 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12743146
7.
Long-term survival with paclitaxel and gemcitabine for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.
Am J Clin Oncol
; 38(4): 373-6, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26214082
8.
Phase II clinical trial of oxaliplatin and bevacizumab in refractory germ cell tumors.
Am J Clin Oncol
; 37(5): 450-3, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23388561
9.
Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group study.
J Clin Oncol
; 30(32): 3998-4003, 2012 Nov 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22915652
10.
Salvage chemotherapy with high-dose carboplatin and etoposide with peripheral blood stem cell transplant in patients with relapsed pure seminoma.
Am J Clin Oncol
; 34(3): 286-8, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20523207
11.
Long-term follow-up of Cisplatin combination chemotherapy in patients with disseminated nonseminomatous germ cell tumors: is a postchemotherapy retroperitoneal lymph node dissection needed after complete remission?
J Clin Oncol
; 28(4): 531-6, 2010 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20026808
12.
Phase II study of paclitaxel plus gemcitabine salvage chemotherapy for germ cell tumors after progression following high-dose chemotherapy with tandem transplant.
J Clin Oncol
; 25(5): 513-6, 2007 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-17290059
13.
Palonosetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancer.
Support Care Cancer
; 15(11): 1293-1300, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17436025
14.
Emetic potential of daily oral etoposide.
Support Care Cancer
; 14(12): 1262-5, 2006 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-16896880
15.
Phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ cell tumors.
J Clin Oncol
; 24(34): 5403-7, 2006 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17135640
16.
Phase II study of imatinib mesylate in chemotherapy refractory germ cell tumors expressing KIT.
Am J Clin Oncol
; 29(1): 12-3, 2006 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16462496
Resultados
1 -
16
de 16
1
Próxima >
>>